Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Talis Biomedical Q4 EPS $(7.39) Up From $(15.15) YoY, Sales $195.00K Down From $257.00K YoY

Author: Benzinga Newsdesk | March 28, 2024 11:28pm
Talis Biomedical (NASDAQ:TLIS) reported quarterly losses of $(7.39) per share. This is a 51.22 percent increase over losses of $(15.15) per share from the same period last year. The company reported $195.00 thousand in sales this quarter. This is a 24.12 percent decrease over sales of $257.00 thousand the same period last year.

Posted In: TLIS


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist